The natural history of B cells

Current Opinion in Neurology

Volumn 21, Issue SUPPL. 1, 2008, Pages

  Monson, Nancy L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmune; B cell; Ectopic; Gene modification; Germinal center

Indexed keywords

ANTIGEN; B LYMPHOCYTE RECEPTOR; CELL SURFACE MARKER; CYTOKINE; IMMUNOGLOBULIN;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DISEASE COURSE; DNA MODIFICATION; EVOLUTION; GERMINAL CENTER; HISTORY; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN GENE; LYMPHOID TISSUE; MEDICAL RESEARCH; MOLECULAR MIMICRY; MOLECULE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOLOGY; REVIEW;

ANTIBODY FORMATION; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BIOLOGICAL MARKERS; GENES, IMMUNOGLOBULIN; GERMINAL CENTER; HUMANS; MULTIPLE SCLEROSIS;

EID: 41649096096     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000313358.53553.c7     Document Type: Review

References (29)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology 2007; 68:326-337.
2. National MS Society, Colorado chapter. National MS society raised concerns that recent NIH study underestimates number of people with MS in the U.S. msconnection 2007; 15(2):21-22.
3. Kobelt G, Berg J, Atherly D, Hadjimichael O. Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology 2006; 66:1696-1702.
4. Dalakas MC. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Pharmacol Ther 2006; 112:57-70.
5. Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006; 6:394-403.
6. Bar-Or A, Oliveira EM, Anderson DE, et al. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J Immunol 2001; 167:5669-5677.
7. Wucherpfennig KW, Catz I, Hausmann S, et al. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 1997; 100:1114-1122.
8. Serafini B, Rosicarelli B, Magliozzi R, et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14:164-174.
9. Corcione A, Casazza S, Ferretti E, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 2004; 101:11064-11069.
10. Avery DT, Ellyard JI, MacKay F, et al. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol 2005; 174:4034-4042.
11. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001; 1:147-153.
12. Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005; 201:195-200.
13. Qin Y, Duquette P. B-cell immunity in MS. Int MS J 2003; 10:110-120.
14. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, et al. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987; 328:805-811.
15. MacLennan IC. Germinal centers. Annu Rev Immunol 1994; 12:117-139.
16. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007; 27:190-202.
17. Boehm T, Bleul CC. The evolutionary history of lymphoid organs. Nat Immunol 2007; 8:131-135.
18. Flajnik MF. Comparative analyses of immunoglobulin genes: surprises and portents. Nat Rev Immunol 2002; 2:688-698.
19. Constant SL. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 1999; 162:5695-5703.
20. Obukhanych TV, Nussenzweig MC. T-independent type II immune responses generate memory B cells. J Exp Med 2006; 203:305-310.
21. Spiegelberg HL. Biological role of different antibody classes. Int Arch Allergy Appl Immunol 1989; 90 (Suppl. 1):22-27.
22. Lynch RG. Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors. Am J Pathol 1998; 152:631-639.
23. Brink BP, Veerhuis R, Breij EC, et al. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005; 64:147-155.
24. Cudrici C, Niculescu T, Niculescu F, et al. Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. J Rehabil Res Dev 2006; 43:123-132.
25. Hughes LE, Smith PA, Bonell S, et al. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 2003; 144:105-115.
26. Esposito M, Venkatesh V, Otvos L, et al. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J Immunol 1999; 163:4027-4032.
27. Westall FC. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 2006; 44:2099-2104.
28. Monson NL, Brezinschek HP, Brezinschek RI, et al. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J Neuroimmunol 2005; 158:170-181.
29. Martin MP, Monson NL. Potential role of humoral immunity in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Front Biosci 2007; 12:2735-2749.